The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on August 18, 2025 for SPB Trustee Company ....
JUBLPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.2 pts more than Nifty Smallcap 250 and 1.5 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
On August 12, 2025, the promoter entities of Jubilant Pharmova — HSB Trustee Company and HS Trustee Company (acting for the Hari Shanker Bhartia Family Trust) and SPB Trustee Company and SS Trustee Company (acting for the Shyam Sunder Bhartia Family Trust) — created a pledge on 41 lakh equity shares in total, equal to about 2.57% of the company's share capital (1.287% from each trust, i.e., 20,50,000 shares each). The pledge is in favour of Bajaj Finance Limited and has been given as security for a loan availed by Jubilant MotorWorks Private Limited, a group company. Prior to this event, neither trust had any pledged or encumbered shares. The disclosure was filed with the stock exchanges on August 18, 2025, as required under the SEBI takeover regulations.
While the pledged portion is relatively small (~2.57%), promoter pledges taken for third-party (group company) borrowings are usually viewed with mild caution by retail investors, as any default could trigger invocation and a potential change in shareholding. The stock is unlikely to react sharply unless further encumbrances or margin issues follow.